Aksigna

Aksigen Hospital Care (AHC) is a research-driven pharmaceutical company headquartered in Mumbai, India, specializing in the development and marketing of specialty drug therapies. Founded in 1994, the company is a pioneer of systemic enzyme therapy in India, introducing innovative combinations like Trypsin, Bromelain, and Rutoside for managing inflammation and pain. AHC maintains a diverse portfolio spanning orthopedics, ophthalmology, nephrology, and fertility care, with established brands such as Aksigna and Phlogam. The company operates WHO-GMP compliant manufacturing facilities and is actively expanding its footprint through both domestic and international partnerships.